Poisoning by oth fibrinolysis-affecting drugs, assault, subs

This code indicates a patient presenting with an adverse effect from an intentional overdose or misuse of a fibrinolysis-affecting drug, other than streptokinase or urokinase, where the intent was assault. The patient is in the subsequent phase of treatment, meaning they are receiving follow-up care after the initial acute phase of the poisoning.

Use this code when documenting ongoing treatment for a patient who was deliberately poisoned by another person using a drug that impacts fibrinolysis (e.g., tissue plasminogen activator, anistreplase). This applies to scenarios such as follow-up appointments, rehabilitation, or management of long-term complications after the initial emergency care for the assault.

• Always assign an additional code for the specific drug involved, if known, from categories T36-T50.
• Remember to also code any associated signs, symptoms, or conditions resulting from the poisoning.
• Ensure the "D" seventh character is appropriate for subsequent encounters; "A" is for initial, and "S" for sequela.